Jump to:

Body Mass Index (BMI)

Body Mass Index (BMI)

Enter the body dimensions below.

Ranges of body mass index : weight(Kg)/height²(m²)

  • <17 - moderate to severe chronic protein-energy malnutrition (severe if <15)
  • 17-20 - chronic protein energy malnutrition but some normal subjects
  • 20-25 - desirable (some authorities 19-25)
  • 25-30 - mildly overweight (grade I obesity)
  • 30-40 - grade II obesity
  • >40 - grade III obesity

Reference:

Weatherall DJ, Ledingham JGG, Warrell DA, editors.
Oxford Textbook of Medicine, 3rd ed.
Oxford: Oxford University Press, 1996;1:1315.

Latest Guidelines

Infliximab (review) and adalimumab for the treatment of Crohn's disease

Technology Appraisal Guidance No. 187 Source: National Institute for Health and...

Febuxostat for the Management of Hyperuricaemia in People with Gout

Technology Appraisal Guidance No. 164 Source: National Institute for Health and Clinical...

Trabectedin for the Treatment of Advanced Soft Tissue Sarcoma

Technology Appraisal Guidance No. 185 Source: National Institute for Health and Clinical...

Certolizumab Pegol for the Treatment of Rheumatoid Arthritis

Technology Appraisal Guidance No. 186 Source: National Institute for Health and Clinical...

Topotecan for the Treatment of Relapsed Small-Cell Lung Cancer

Technology Appraisal Guidance No. 184 Source: National Institute for Health and Clinical...

 

GP Curriculum Centre

Educational resource for the learning and teaching of the
GP curriculum

Click here to read more

Deleted products

Cumulative list of products discontinued from the UK market
in 2010

Click here to read more

Treating psoriasis

Healthcare Republic resource centre for diagnosing and managing psoriasis

Click here to read more

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

NICE Guidance: Lipid Modification

NICE Lipid Modification

MIMS Summary of
NICE guideline

Comparison table: contraceptives

Contraceptives Table

Combined, phasic and progestogen-only preparations

 

Back to top